BCL2 and cancer: In triple negative breast (TNBC) cancer cell lines, HHT was demonstrated to strongly decrease survival influenced by MCL-1, BCL-2, SURVIVIN, XIAP and could reduce cancer growth of MDA-MB-231 xenografts [99].